ATA Thyroid Cancer | Conference

MSKCC Implementation of Active Surveillance for Thyroid Cancer
September 29, 2016

Memorial Sloan Kettering Cancer Center’s experience shows that selected patients with low-risk papillary thyroid cancer can safely defer surgery in favor of active surveillance.

I-131 for Thyroid Cancer Metastases
September 28, 2016

In this interview we discuss which distant metastases in thyroid cancer are appropriate targets for I-131 treatment, appropriate dosing, and more.

PI3K, HDAC Inhibition With CUDC-907 Shows Promise in Thyroid Cancer
September 27, 2016

Dual inhibition of PI3K signaling and histone deacetylase 2 (HDAC2) enzymes with CUDC-907 slowed thyroid tumor cell proliferation, tumor progression and metastasis, according to a preclinical study.